These results are consistent with our previous findings, which indicated that the loss of Caspase-8 causes a cellular over-activity of CDK9 and highlights the critical role of Caspase-8 in improving the response and sensitivity of cervical cancer to CDK9 inhibition. The gene discussed is CDK9; the disease is cervical carcinoma.